PRIORITY MEDICINE. IN PRACTICE.

Details for Australian Trade Mark No. 924930 (hide)

Owner Celgene Corporation

Service Banki Haddock Fiora Lawyers Level **** Street SYDNEY NSW 2000 AUSTRALIA

Various Convention priority claimed: 28 February 2002, United States of America, No. 78/111821 in respect of PHARMACEUTICALS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER, BLOOD DISEASE AND CARDIOVASCULAR DISEASE IN HUMANS.*

Classes

Class 5 Pharmaceuticals; pharmaceutical preparations for the treatment of cancer, blood disease and cardiovascular disease in humans; veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides

Event Publications

26 June 2008 Subsequent Owners/Holder Registered - Full Assignment

  Pharmion Corporation a Delaware corporation is the full asignee of Celgene Corporation.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

924931-O

924926-SPLICE